SCHEMBL9020939

SCHEMBL9020939

CC(=O)S[C@H]1C[C@@H](C2CCN(C(=O)OC(C)(C)C)C2)N(C(=O)OCc2ccc([N+](=O)[O-])cc2)C1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 2/20 0.44
ALDH1A1 P00352 2/20 0.42
MAPT P10636 2/20 0.42
LMNA P02545 1/20 0.42
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40
HPGD P15428 1/20 0.38
NR1D1 P20393 2/20 0.38
ATM Q13315 1/20 0.36
GPR119 Q8TDV5 6/20 0.35
TDP1 Q9NUW8 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9020729 0.94 CCR5 (0.42) CCR5ALDH1A1MAPTLMNAHPGD
SCHEMBL9020004 0.90 CCR5 (0.41) CCR5ALDH1A1MAPTLMNAHPGD
SCHEMBL9399680 0.86 CCR5 (0.42) CCR5ALDH1A1MAPTHPGDATM
SCHEMBL9020258 0.86 ALDH1A1 (0.42) CCR5ALDH1A1MAPTLMNAJAK2
SCHEMBL9021016 0.84 CCR5 (0.46) CCR5ALDH1A1MAPTLMNAJAK2
SCHEMBL9020556 0.83 CCR5 (0.43) CCR5ALDH1A1MAPTLMNAJAK2
SCHEMBL9399794 0.83 CCR5 (0.48) CCR5ALDH1A1MAPTLMNAJAK2
SCHEMBL9020407 0.81 ALDH1A1 (0.41) CCR5ALDH1A1MAPTHPGDATM
SCHEMBL9020195 0.81 ALDH1A1 (0.41) CCR5ALDH1A1MAPTHPGDATM
SCHEMBL9519199 0.80 PREP (0.43) CCR5ALDH1A1MAPTHPGDATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0449191-B1 2-(Substituted pyrrolidinylthio)carbapenem derivatives BANYU PHARMA CO LTD (JP) 1996-07-03 EP disclosed
US-5438054-A Antibacterial agent BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-01 US disclosed
US-5374720-A A thienamycins bactericides has nontoxic, side effect reduction against the kidney and central nervous system BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-12-20 US disclosed
WO-1991014687-A1 2-(SUBSTITUTED PYRROLIDINYLTHIO)CARBAPENEM DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1991-10-03 WO disclosed
EP-0449191-A1 2-(Substituted pyrrolidinylthio)carbapenem derivatives Banyu Pharmaceutical Co., Ltd. (JP) 1991-10-02 EP disclosed